Latest Marketable Securities News

Page 4 of 5
EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.
Ada Torres
Ada Torres
14 May 2025
AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.
Ada Torres
Ada Torres
9 May 2025
Novo Resources reported a reduced net loss of CAD 1.625 million in Q1 2025, progressing exploration with a new aircore drilling program in Western Australia while facing liquidity challenges that cast doubt on its near-term financial sustainability.
Maxwell Dee
Maxwell Dee
7 May 2025
Contact Energy has received clearance from the New Zealand Commerce Commission to proceed with its acquisition of Manawa Energy, marking a pivotal step in the country’s energy transition.
Maxwell Dee
Maxwell Dee
7 May 2025
Argenica Therapeutics has completed patient dosing in its Phase 2 trial of ARG-007 for acute ischaemic stroke, with topline data expected in Q3 2025. The company also plans to submit its Investigational New Drug application and Fast Track request to the FDA imminently.
Ada Torres
Ada Torres
30 Apr 2025
Contact Energy reported a 12% rise in EBITDAF to $404 million for 1H25, driven by new geothermal assets and strategic contracts, while net profit fell 7% due to market volatility and acquisition costs.
Maxwell Dee
Maxwell Dee
17 Feb 2025
AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.
Ada Torres
Ada Torres
14 Feb 2025
De.mem Limited has secured a strategic distribution agreement with Singapore’s Firmbase Pte Ltd to penetrate key Asian markets, including China, Indonesia, and Japan, marking its first commercial sale in China’s burgeoning home water filtration sector.
Victor Sage
Victor Sage
11 Feb 2025
Mayne Pharma reports a robust first half of FY25 with revenues climbing to $210-$215 million and underlying EBITDA soaring by up to 300%, driven by strong performance in Women's Health.
Victor Sage
Victor Sage
10 Feb 2025
DomaCom Limited reports a transformative quarter with executive changes, new funding facilities, and strategic initiatives including the launch of its Homeowner Equity Fund and exclusive licensing of the Bricklet Homeowner Platform.
Claire Turing
Claire Turing
3 Feb 2025
NOVONIX has advanced its position in the battery materials sector with a conditional US$754 million loan commitment from the U.S. Department of Energy and binding offtake agreements with automotive giants Stellantis and PowerCo. These milestones underpin its expansion plans for synthetic graphite production in North America.
Victor Sage
Victor Sage
31 Jan 2025
BluGlass Limited has secured over A$4 million in new contracts and filed three US patents for high-power tunable GaN lasers, reinforcing its leadership in visible laser technology and expanding its footprint in strategic photonics markets.
Victor Sage
Victor Sage
31 Jan 2025